Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of cyclin-dependent kinase 7 (CDK7)

Inhibitors of cyclin-dependent kinase 7 (CDK7)

US Patent 10106526 · Granted Oct 23, 2018

Estimated economic value: $4,194,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimid2025
Treatment of fibrosis with IRE1 small molecule inhibitors2025
Pyridazine compounds for inhibiting NLRP32025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors2025
Polo like kinase 4 inhibitors2025
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
Therapeutic compounds and methods of use2025
Inhibitors of cyclin-dependent kinase 7 (CDK7)2025